Pro all tutvustatud IDTI saab täna positiivset tähelepanu Barclay'lt:
Integrated Device tgt raised to $7 from $6 at Barclays to reflect recent acquisition of Tundra & the sale of the NSE division to Netlogic as well as checks.
USA indeksid alustavad 2009. aasta esimese poole viimast kauplemispäeva eilsete sulgumistasemete lähedalt, väikeses plussis.
Euroopa turud:
Saksamaa DAX -0.07%
Prantsusmaa CAC 40 -0.48%
Inglismaa FTSE 100 -0.18%
Hispaania IBEX 35 -0.09%
Venemaa MICEX +1.40%
Poola WIG +1.04%
Aasia turud:
Jaapani Nikkei 225 +1.79%
Hong Kongi Hang Seng -0.81%
Hiina Shanghai A (kodumaine) -0.54%
Hiina Shanghai B (välismaine) +0.52%
Lõuna-Korea Kosdaq -1.32%
Tai Set 50 -0.84%
India Sensex 30 -1.97%
Bulls Have the Ball as the Quarter Ends
By Rev Shark
RealMoney.com Contributor
6/30/2009 8:56 AM EDT
If I'd had some set idea of a finish line, don't you think I would have crossed it years ago?
-- Bill Gates
Today we reach the end of the second quarter of 2009. By almost every measure it was quite a positive one, and what was most notable was how steadily we improved once the bounce began back in early March. Nearly four months later we have had only shallow pullbacks of limited durations, and underlying support continues to be quite strong.
The obvious question is whether the worst really is over for the stock market. Plenty of folks believe the economy is starting to heal and the pace of decline is slowing, but does that mean the market will continue to trend steadily higher? Is the bear market produced by the worst economy since the Great Depression really over?
At this point, the indices aren't showing us any major warning signs that we are about to fall apart. We stumbled a little and found technical support around the 50- and 200-day simple moving averages of the S&P 500. With the help of the Russell rebalancing and some window dressing to conclude the quarter, we have been slowly bouncing off that support and are in the middle of a trading range but facing some overhead on the last day of the quarter.
Since this rally began back in March, buyers have continuously been quite quick to buy any dip. There was some concern that maybe that approach was going to stop working a week or so ago, but we did hold support and the dip-buyers were rewarded once again. The bears' theory at this point is that it was the end-of-the-quarter manipulation that saved the bulls this time but with that driver ending today, the risks to the downside are growing.
Given the mildness of the bounce over the past week, I tend to believe we are due for a further pullback, but I don't see any great technical evidence yet that the bulls have lost control of the market. They keep plugging away steadily, and overly aggressive shorts keep providing short squeeze fuel.
With the quarter over and then what will likely be two lower-volume days in front of the Fourth of July holiday, the likelihood is that trading will become quite choppy. Further upside is going to be difficult with 930 of the S&P 500 lurking overhead, but trading around holidays tends to have a positive bias.
We have some positive analyst comments and a slightly positive open this morning. A lot of economic news is hitting, and that'll bounce us around. I'm looking for trendless and choppy action.
-----------------------------
Ülespoole avanevad:
In reaction to strong earnings/guidance: APOL +6.4%, HRB +5.3%... Select stem cell related names showing strength following GERN (+18.5%) news: GERN +18.5% (Geron and GE Healthcare announce exclusive global agreement to commercialize stem cell drug discovery technologies), STEM +11.9%, ASTM +10.0%... Select financial names showing strength: AIB +4.8%, KEY +3.8%, BCS +3.5%, UBS +1.9% (selling Park Ave stake - NY Post), LYG +1.7%... Select education related names trading higher following APOL results: COCO +4.9%, DV +2.3%, ESI +2.0%, CECO +1.5%... Other news: VICL +18.2% (Vical H1 influenza vaccine delivers robust preclinical results with 100% response), XCO +7.9% (announces agreement with BG Group for joint development of its Haynesville Shale and other operations in East Texas/North Louisiana), HEB +6.2% (still checking), MNTA +4.8% (announces EMINENCE Phase 2 trial achieves primary endpoint), MEDX +2.7% (to receive milestone payment for the approval of Ilaris for the treatment of cryopyrin-associated periodic syndrome), GNW +1.8% (priced its IPO in Canada of 44.7 mln common shares at Cdn$19.00/share), SNY +1.8% (still checking), GLW +1.4% (announces improved Q2 LCD volume performance)... Analyst comments: ERTS +3.3% (upgraded to Buy at BofA/Merrill and ests raised at Lazard Capital Mkts ahead of the qtr), IPI +2.0% (initiated with an Outperform at RBC), FDX +1.5% (upgraded to Overweight at Barclays), FCX +1.3% (upgraded to Buy at Canaccord), RIMM +0.9% (initiated with an Outperform and sets a $100 tgt at BMO).
Allapoole avanevad:
In reaction to disappointing earnings/guidance: SCHN -4.1%... M&A news: ELX -2.1% (Broadcom raises all-cash tender offer for Emulex to $11.00/share)... Select ag/chem related names showing weakness: MOS -1.6%, POT -1.5%, AGU -1.1%, MON -1.1%... Other news: TKG -56.1% (trading ex dividend), SRZ -16.3% (HCP initiates litigation against Sunrise Senior Living), PSEC -4.8% (announces commencement of public offering of 4 mln shares of common stock), TTM -4.3% (still checking), ABT -2.2% (Centocor Ortho Biotech awarded $1.67 bln patent jury verdict from Abbott Labs), ASBC -2.0% (increase in loan loss provision for Q2)... Analyst comments: KDN -3.7% (light volume; downgraded to Mkt Perform at Barrington Research), HOT -2.8% (downgraded to Market Perform at Wachovia), AMR -2.8% (downgraded to Sell at Argus), SO -2.7% (downgraded to Hold at Citigroup), TSO -2.2% and SUN -1.3% (downgraded to Sell from Neutral at Goldman - Reuters), SNDA -1.3% (downgraded to Hold at Brean Murray).
By Rev Shark
RealMoney.com Contributor
6/30/2009 8:56 AM EDT
If I'd had some set idea of a finish line, don't you think I would have crossed it years ago?
-- Bill Gates
Today we reach the end of the second quarter of 2009. By almost every measure it was quite a positive one, and what was most notable was how steadily we improved once the bounce began back in early March. Nearly four months later we have had only shallow pullbacks of limited durations, and underlying support continues to be quite strong.
The obvious question is whether the worst really is over for the stock market. Plenty of folks believe the economy is starting to heal and the pace of decline is slowing, but does that mean the market will continue to trend steadily higher? Is the bear market produced by the worst economy since the Great Depression really over?
At this point, the indices aren't showing us any major warning signs that we are about to fall apart. We stumbled a little and found technical support around the 50- and 200-day simple moving averages of the S&P 500. With the help of the Russell rebalancing and some window dressing to conclude the quarter, we have been slowly bouncing off that support and are in the middle of a trading range but facing some overhead on the last day of the quarter.
Since this rally began back in March, buyers have continuously been quite quick to buy any dip. There was some concern that maybe that approach was going to stop working a week or so ago, but we did hold support and the dip-buyers were rewarded once again. The bears' theory at this point is that it was the end-of-the-quarter manipulation that saved the bulls this time but with that driver ending today, the risks to the downside are growing.
Given the mildness of the bounce over the past week, I tend to believe we are due for a further pullback, but I don't see any great technical evidence yet that the bulls have lost control of the market. They keep plugging away steadily, and overly aggressive shorts keep providing short squeeze fuel.
With the quarter over and then what will likely be two lower-volume days in front of the Fourth of July holiday, the likelihood is that trading will become quite choppy. Further upside is going to be difficult with 930 of the S&P 500 lurking overhead, but trading around holidays tends to have a positive bias.
We have some positive analyst comments and a slightly positive open this morning. A lot of economic news is hitting, and that'll bounce us around. I'm looking for trendless and choppy action.
-----------------------------
Ülespoole avanevad:
In reaction to strong earnings/guidance: APOL +6.4%, HRB +5.3%... Select stem cell related names showing strength following GERN (+18.5%) news: GERN +18.5% (Geron and GE Healthcare announce exclusive global agreement to commercialize stem cell drug discovery technologies), STEM +11.9%, ASTM +10.0%... Select financial names showing strength: AIB +4.8%, KEY +3.8%, BCS +3.5%, UBS +1.9% (selling Park Ave stake - NY Post), LYG +1.7%... Select education related names trading higher following APOL results: COCO +4.9%, DV +2.3%, ESI +2.0%, CECO +1.5%... Other news: VICL +18.2% (Vical H1 influenza vaccine delivers robust preclinical results with 100% response), XCO +7.9% (announces agreement with BG Group for joint development of its Haynesville Shale and other operations in East Texas/North Louisiana), HEB +6.2% (still checking), MNTA +4.8% (announces EMINENCE Phase 2 trial achieves primary endpoint), MEDX +2.7% (to receive milestone payment for the approval of Ilaris for the treatment of cryopyrin-associated periodic syndrome), GNW +1.8% (priced its IPO in Canada of 44.7 mln common shares at Cdn$19.00/share), SNY +1.8% (still checking), GLW +1.4% (announces improved Q2 LCD volume performance)... Analyst comments: ERTS +3.3% (upgraded to Buy at BofA/Merrill and ests raised at Lazard Capital Mkts ahead of the qtr), IPI +2.0% (initiated with an Outperform at RBC), FDX +1.5% (upgraded to Overweight at Barclays), FCX +1.3% (upgraded to Buy at Canaccord), RIMM +0.9% (initiated with an Outperform and sets a $100 tgt at BMO).
Allapoole avanevad:
In reaction to disappointing earnings/guidance: SCHN -4.1%... M&A news: ELX -2.1% (Broadcom raises all-cash tender offer for Emulex to $11.00/share)... Select ag/chem related names showing weakness: MOS -1.6%, POT -1.5%, AGU -1.1%, MON -1.1%... Other news: TKG -56.1% (trading ex dividend), SRZ -16.3% (HCP initiates litigation against Sunrise Senior Living), PSEC -4.8% (announces commencement of public offering of 4 mln shares of common stock), TTM -4.3% (still checking), ABT -2.2% (Centocor Ortho Biotech awarded $1.67 bln patent jury verdict from Abbott Labs), ASBC -2.0% (increase in loan loss provision for Q2)... Analyst comments: KDN -3.7% (light volume; downgraded to Mkt Perform at Barrington Research), HOT -2.8% (downgraded to Market Perform at Wachovia), AMR -2.8% (downgraded to Sell at Argus), SO -2.7% (downgraded to Hold at Citigroup), TSO -2.2% and SUN -1.3% (downgraded to Sell from Neutral at Goldman - Reuters), SNDA -1.3% (downgraded to Hold at Brean Murray).
Tallinna börsil oli kena poolaasta vormistamine YHI poolt.
OEG, TKM .. väga palju maksma ei läinud :D
OEG, TKM .. väga palju maksma ei läinud :D
June Chicago PMI 39.9 vs 39.0 consensus, prior 34.9
June Consumer Confidence 49.3 vs 55.3 consensus, prior 54.9